Abstract
New and more active concepts of steroid binding globulin action are emerging from
recent research. As a result, examination of steroid levels in aging humans and the
role of steroid binding globulins need to be re-visited. This review will discuss
the possibility that sex hormone binding globulin (SHBG) plays an active role in the
aging process. It will discuss the changes in blood levels of SHBG in aging humans
in association with sexual activity, prostate hypertrophy and cancer, uterine leiomyoma,
breast cancer, obesity and particularly the relationship between SHBG and HDL-cholesterol,
Alzheimer's disease, osteoporosis, and cardiovascular disease. Starting with the idea
that SHBG is an active participant in steroid action demands a re-evaluation of data
demonstrating a primary change in blood SHBG levels in association with various pathologies.
Here we discuss the postulate that SHBG may act at its own receptor at the plasma
membrane level to influence other receptors such as scavenger receptors and HDL-cholesterol
receptors. We will also suggest that SHBG is a critical marker for mating and thus
may be an important physiological molecule in control of aging.
Key words
aging - SHBG - steroids - osteoporosis - Alzheimer's disease - obesity - HDL-cholesterol
- CD36 - CBG - estradiol - testosterone - dihydrotestosterone
References
- 1
Mendel CM.
The free hormone hypothesis: a physiologically based mathematical model.
Endocr Rev.
1989;
10
232-274
- 2
Pardridge WM.
Transport of protein-bound hormones into tissues in vivo.
Endocr Rev.
1981;
2
103-123
- 3
Pardridge WM, Eisenberg J, Fierer G, Musto NA.
Developmental changes in brain and serum binding of testosterone and in brain capillary
uptake of testosterone-binding serum proteins in the rabbit.
Brain Res.
1988;
466
245-253
- 4
Hryb DJ, Khan MS, Romas NA, Rosner W.
Solubilization and partial characterization of the sex hormone- binding globulin receptor
from human prostate.
J Biol Chem.
1989;
264
5378-5383
- 5
Hryb DJ, Khan MS, Romas NA, Rosner W.
The control of the interaction of sex hormone-binding globulin with its receptor by
steroid hormones.
J Biol Chem.
1990;
265
6048-6054
- 6
Khan MS, Hryb DJ, Hashim GA, Romas NA, Rosner W.
Delineation and synthesis of the membrane receptor-binding domain of sex hormone-binding
globulin.
J Biol Chem.
1990;
265
18362-18365
- 7
Nakhla AM, Leonard J, Hryb DJ, Rosner W.
Sex hormone-binding globulin receptor signal transduction proceeds via a G protein.
Steroids.
1999;
64
213-216
- 8
Nakhla AM, Khan MS, Rosner W.
Biologically active steroids activate receptor-bound human sex hormone-binding globulin
to cause LNCaP cells to accumulate adenosine 3′5′-monophosphate.
J Clin Endocrinol Metab.
1990;
71
398-404
- 9
Porto CS, Gunsalus GL, Bardin CW, Phillips DM, Musto NA.
Receptor-mediated endocytosis of an extracellular steroid-binding protein (TeBG) in
MCF-7 human breast cancer cells.
Endocrinology.
1991;
129
436-445
- 10
Meyer S, Brumm C, Stegner HE, Sinnecker GH.
Intracellular sex hormone-binding globulin (SHBG) in normal and neoplastic breast
tissue – an additional marker for hormone dependency?.
Exp Clin Endocrinol.
1994;
102
334-340
- 11
Hammond GL, Bocchinfuso WP.
Sex hormone binding globulin/Androgen binding protein: Steroid-binding and dimerization
domains.
J Steroid Biochem Mole Biol.
1995;
53
543-562
- 12
Sakiyama R, Pardridge WM, Musto NA.
Influx of testosterone-binding globulin (TeBG) and TeBG-bound sex steroid hormone
into rat testis and prostate.
J Clin Endocrinol Metab.
1988;
67
98-103
- 13
Allera A, Wildt L.
Glucocorticoid-recognizing and -effector sites in rat liver plasma membrane. Kinetics
of corticosterone uptake by isolated membrane vesicles-II. Comparative influx and
efflux.
J Steroid Biochem Mol Biol.
1992;
42
757-771
- 14
Christensen EI, Moskaug JO, Vorum H, Jacobsen C, Gundersen TE, Nykjaer A, Blomhoff R,
Willnow TE, Moestrup SK.
Evidence for an essential role of megalin in transepithelial transport of retinol.
J Am Soc Nephrol.
1999;
10
685-695
- 15
Nykjaer A, Dragun D, Walther D, Vorum H, Jacobsen C, Herz J, Melsen F, Christensen EI,
Willnow TE.
An endocytic pathway essential for renal uptake and activation of the steroid 25-(OH)
vitamin D3.
Cell.
1999;
96
507-515
- 16
Hammes A, Andreassen TK, Spoelgen R, Raila J, Hubner N, Schulz H, Metzger J, Schweigert FJ,
Luppa PB, Nykjaer A, Willnow TE.
Role of endocytosis in cellular uptake of sex steroids.
Cell.
2005;
122
751-762
- 17
Caldwell JD, Shapiro RA, Jirikowski GF, Suleman F.
Internalization of sex hormone-binding globulin into neurons and brain cells in vitro
and in vivo.
Neuroendocrinology.
2007;
86
84-93
- 18
Caldwell JD, Suleman F, Jirikowski GF.
Internalization of sex hormone binding globulin into fibroblast 3T3 cells.
Horm Metabl Res.
2007;
39
620-621
- 19
Willnow TE, Nykjaer A, Herz J.
Lipoprotein receptors: new roles for ancient proteins.
Nat Cell Biol.
1999;
1
E157-E162
- 20
Petersen HH, Andreassen TK, Breiderhoff T, Brasen JH, Schulz H, Gross V, Grone HJ,
Nykjaer A, Willnow TE.
Hyporesponsiveness to glucocorticoids in mice genetically deficient for the corticosteroid
binding globulin.
Mol Cell Biol.
2006;
26
7236-7245
- 21
Burkhardt MS, Foster JK, Clamette RM, Bruce DG, Drummond PD, Martins RN, Yeap BB.
Interaction between testosterone and apolipoprotein E epsilon4 status on cognition
in healthy older men.
J Clin Endocrinol Metab.
2006;
91
1168-1172
- 22
Dechaud H, Denuziere A, Rinaldi S, Bocquet J, Lejeune H, Pugeat M.
Age-associated discrepancy between measured and calculated bioavailable testosterone
in men.
Clin Chem.
2007;
53
723-728
- 23
Ferrini RL, Barrett-Connor E.
Sex hormones and age: a cross-sectional study of testosterone and estradiol and their
bioavailable fractions in community-dwelling men.
Am J Epidemiol.
1998;
147
750-754
- 24
Rosner W, Auchus RJ, Azziz R, Sluss PM, Raff H.
Position statement: Utility, limitations, and pitfalls in measuring testosterone:
an Endocrine Society position statement.
J Clin Endocrinol Metab.
2007;
92
405-413
- 25
Siiteri PK, Murai JT, Hammond GL, Nisker JA, Raymoure WJ, Kuhn RW.
The serum transport of steroid hormones.
Recent Prog Horm Res.
1982;
38
457-510
- 26
Muller M, den Tonkelaar I, Thijssen JH, Grobbee DE, Schouw YT van der.
Endogenous sex hormones in men aged 40–80 years.
Eur J Endocrinol.
2003;
149
583-589
- 27
Kaaks R, Rinaldi S, Key TJ, Berrino F, Peeters PH, Biessy C, Dossus L, Lukanova A,
Bingham S, Khaw KT, Allen NE, Bueno-de-Mesquita HB, Gils CH van, Grobbee DE, Boeing H,
Lahmann PH, Nagel G, Chang-Claude J, Clavel-Chapelon F, Fournier A, Thiebaut A, Gonzalez CA,
Quiros JR, Tormo MJ, Ardanaz E, Amiano P, Krogh V, Palli D, Panico S, Tumino R, Vineis P,
Trichopoulou A, Kalapothaki V, Trichopoulos D, Ferrari P, Norat T, Saracci R, Riboli E.
Postmenopausal serum androgens, oestrogens and breast cancer risk: the European prospective
investigation into cancer and nutrition.
Endocr Relat Cancer.
2005;
12
1071-1082
- 28
Rapuri PB, Gallagher JC, Haynatzki G.
Endogenous levels of serum estradiol and sex hormone binding globulin determine bone
mineral density, bone remodeling, the rate of bone loss, and response to treatment
with estrogen in elderly women.
J Clin Endocrinol Metab.
2004;
89
4954-4962
- 29
Hoskins EK, Tang MX, Manly JJ, Mayeux R.
Elevated sex-hormone binding globulin in elderly women with Alzheimer's disease.
Neurobiol Aging.
2004;
25
141-147
- 30
Pennanen C, Laakso MP, Kivipelto M, Ramberg J, Soininen H.
Serum testosterone levels in males with Alzheimer's disease.
J Neuroendocrinol.
2004;
16
95-98
- 31
Hogervorst E, Combrinck M, Smith AD.
Testosterone and gonadotropin levels in men with dementia.
Neuro Endocrinol Lett.
2003;
24
203-208
- 32
Edmunds SE, Stubbs AP, Santos AA, Wilkinson ML.
Estrogen and androgen regulation of sex hormone binding globulin secretion by a human
liver cell line.
J Steroid Biochem Mol Biol.
1990;
37
733-739
- 33
Gao G, Herbert Z, Kong J, Wu D, Gabrielson N, Jirikowski GF, Caldwell JD.
Estradiol control of estradiol binding proteins and levels in the medial preoptic
area, medial hypothalamus and pituitary.
Neuroendocrinology.
2003;
78
61-71
- 34
DeCherney AH.
Hormone receptors and sexuality in the human female.
J Womens Health Gend Based Med.
2000;
9
S9-S13
- 35
Warnock JK, Clayton A, Croft H, Segraves R, Biggs FC.
Comparison of androgens in women with hypoactive sexual desire disorder: those on
combined oral contraceptives (COCs) vs. those not on COCs.
J Sex Med.
2006;
3
878-882
- 36
Caldwell JD, Moe BD, Hoang J, Nguyen T.
Sex hormone binding globulin stimulates female sexual receptivity.
Brain Res.
2000;
874
24-29
- 37
Caldwell JD, Hoefle S, Englof I.
Sex hormone binding globulin facilitates female sexual receptivity except when coupled
to dihydrotestosterone.
Brain Res.
2002;
948
102-107
- 38
Caldwell JD, Prange Jr AJ, Pedersen CA.
Oxytocin facilitates the sexual receptivity of estrogen-treated female rats.
Neuropeptides.
1986;
7
175-189
- 39
Caldwell JD, Pedersen CA, Prange Jr AJ.
Oxytocin facilitates sexual behavior in estrogen-treated ovariectomized rats.
J Steroid Biochem.
1984;
20
1510
- 40
Rosner W, Hryb DJ, Khan MS, Nakhla AM, Romas NA.
Sex hormone-binding globulin: anatomy and physiology of a new regulatory system.
J Steroid Biochem Mol Biol.
1991;
40
813-820
- 41
Wang YM, Bayliss DA, Millhorn DE, Petrusz P, Joseph DR.
The androgen-binding protein gene is expressed in male and female rat brain.
Endocrinology.
1990;
127
3124-3130
- 42
Herbert Z, Jirikowski GF, Petrusz P, Englof I, Caldwell JD.
Distribution of androgen binding globulin in the rat hypothalamo-hypophyseal system,
co-localization with oxytocin.
Brain Res.
2003;
992
151-158
- 43
Herbert Z, Gothe S, Caldwell JD, Bernstein HG, Melle C, Lewis J, Jirikowski GF.
Characterization of sex hormone binding globulin (SHBG) in the human hypothalamus.
Neuroendocrinology.
2005;
81
286-293
- 44
Caldwell JD.
A sexual arousability model involving steroid effects at the plasma membrane.
Neurosc Biobehav Rev.
2002;
26
13-30
- 45
Herbert Z, Weigel S, Marshall A, Caldwell JD, Petrusz P, Peuckert C, Jirikowski GF.
Coexpression of androgen-binding protein (ABP) and oxytocin in the male reproductive
tract.
Anat Histol Embryol.
2005;
34
293
- 46
Nyunt A, Stephen G, Gibbin J, Durgan L, Fielding AM, Wheeler M, Price DE.
Androgen status in healthy premenopausal women with loss of libido.
J Sex Marital Ther.
2005;
31
73-80
- 47
Schreiner-Engel P, Schiavi RC, White D, Ghizzani A.
Low sexual desire in women: the role of reproductive hormones.
Horm Behav.
1989;
23
221-234
- 48
Popovic A, Plecas B, Milicevic Z, Hristic M, Jovovic D.
Stereologic analysis of ventral prostate of oxytocin-treated rats.
Arch Androl.
1990;
24
247-253
- 49
Assinder SJ, Whittington K, Nicholson HD.
Differential expression of oxytocin and its receptor in prostate tissue from patients
with benign or malignant prostate disease.
J Androl.
2001;
May/June
P3-4-119
- 50
Hryb DJ, Khan MS, Rosner W.
Testosterone-estradiol-binding globulin binds to human prostatic cell membranes.
Biochem Biophys Res Commun.
1985;
128
432-440
- 51
Nakhla AM, Khan MS, Rosner W.
Induction of adenylate cyclase in a mammary carcinoma cell line by human corticosteroid-binding
globulin.
Biochem Biophys Res Commun.
1988;
153
1012-1018
- 52
Nakhla AM, Khan MS, Romas NP, Rosner W.
Estradiol causes the rapid accumulation of cAMP in human prostate.
Proc Natl Acad Sci USA.
1994;
91
5402-5405
- 53
Rosner W, Hryb DJ, Khan MS, Nakhla AM, Romas NA.
Androgen and estrogen signaling at the cell membrane via G-proteins and cyclic adenosine
monophosphate.
Steroids.
1999;
64
100-106
- 54
Nakhla AM, Romas NA, Rosner W.
Estradiol activates the prostate androgen receptor and prostate specific antigen secretion
through the intermediacy of sex hormone binding globulin.
J Biol Chem.
1997;
272
6838-6841
- 55
Plymate SR, Loop SM, Hoop RC, Wiren KM, Ostenson R, Hryb DJ, Rosner W.
Effects of sex hormone binding globulin (SHBG) on human prostatic carcinoma.
J Steroid Biochem Mol Biol.
1991;
40
833-839
- 56
Castoria G, Barone MV, Domenico M Di, Bilancio A, Ametrano D, Migliaccio A, Auricchio F.
Non-transcriptional action of oestradiol and progestin triggers DNA synthesis.
EMBO J.
1999;
18
2500-2510
- 57
Castoria G, Lombardi M, Barone MV, Bilancio A, Domenico M Di, Falco A de, Varrichio L,
Bottero D, Nanayakkara M, Migliaccio A, Auricchio F.
Rapid signalling pathway activation by androgens in epithelial and stromal cells.
Steroids.
2004;
69
517-522
- 58
Bordin S, Petra PH.
Immunocytochemical localization of the sex steroid-binding protein of plasma in tissues
of the adult monkey Macaca nemestrina.
Proc Natl Acad Sci USA.
1980;
77
5678-5682
- 59
Chambliss KL, Shaul PW.
Estrogen modulation of endothelial nitric oxide synthase.
Endocrine Rev.
2002;
23
665-686
- 60
Avvakumov GV, Zhuk NI, Strel’chyonok OA.
Subcellular distribution and selectivity of the protein-binding component of the recognition
system for sex-hormone-binding protein-estradiol complex in human decidual endometrium.
Biochim Biophys Acta.
1986;
881
489-498
- 61
Avvakumov GV, Krupenko SA, Strel'chyonok OA.
Study of the transcortin binding to human endometrium plasma membrane.
Biochim Biophys Acta.
1989;
984
143-150
- 62
Krupenko SA, Avvakumov GV, Strel’chyonok OA.
A transcortin-binding protein in the plasma membrane of human syncytiotrophoblast.
Biochem Biophys Res Commun.
1991;
177
834-839
- 63
Krupenko SA, Avvakumov GV, Strel’chyonok OA.
On the functional form of transcortin-recognizing subunit of transcortin membrane
receptor.
FEBS Lett.
1991;
281
152-154
- 64
Strel’chyonok OA, Avvakumov GV, Survilo LJ.
A recognition system for sex-hormone binding protein-estradiol complex in human decidual
endometrium plasma membranes.
Biochim Biophys Acta.
1984;
802
459-466
- 65
Misao R, Fujimoto J, Itoh N, Nakanishi Y, Tamaya T.
Localization of sex hormone-binding globulin mRNA expression in human uterine endometrium.
Gynecol Endocrinol.
1997;
11
1-4
- 66
Misao R, Nakanishi Y, Fujimoto J, Tamaya T.
Expression of sex hormone-binding globulin exon VII splicing variant mRNA in human
uterine myometrium and leiomyoma.
J Steroid Biochem Mol Biol.
1997;
63
269-274
- 67
Misao R, Nakanishi Y, Fujimoto J, Tamaya T.
Expression of sex hormone-binding globulin mRNA in uterine leiomyoma, myometrium and
endometrium of human subjects.
Gynecol Endocrinol.
1995;
9
317-323
- 68
Misao R, Nakanishi Y, Fujimoto J, Hori M, Ichigo S, Tamaya T.
Expression of sex hormone-binding globulin mRNA in uterine cervical cancers.
Tumour Biol.
1997;
18
6-12
- 69
Fissore F, Fortunati N, Comba A, Fazzari A, Gaidano G, Berta L, Frairia R.
The receptor-mediated action of sex steroid binding protein (SBP, SHBG): accumulation
of cAMP in MCF-7 cells under SBP and estradiol treatment.
Steroids.
1994;
59
661-667
- 70
Fortunati N, Fissore F, Fazzari A, Berta L, Benedusi-Pagliano E, Frairia R.
Biological relevance of the interaction between sex steroid binding protein and its
specific receptor of MCF-7 cells: effect on the estradiol-induced cell proliferation.
J Steroid Biochem Mol Biol.
1993;
45
435-444
- 71
Frairia R, Fortunati N, Fazzari A, Fissore F, Comba A, Becchis M, Catalano MG, Benedusi-Pagliano E,
Berta L, Mauro M, Gaidano G.
Sex steroid binding protein is a negative modulator of estrogen- induced breast cancer
cell growth.
Ann N Y Acad Sci.
1996;
784
362-369
- 72
Fortunati N, Fissore F, Comba A, Becchis M, Catalano MG, Fazzari A, Berta L, Frairia R.
Sex steroid-binding protein and its membrane receptor in estrogen- dependent breast
cancer: biological and pathophysiological impact.
Horm Res.
1996;
45
202-206
- 73
Fortunati N, Raineri M, Cignetti A, Hammond GL, Frairia R.
Control of the membrane sex hormone-binding globulin-receptor (SHBG-R) in MCF-7 cells:
effect of locally produced SHBG.
Steroids.
1998;
63
282-284
- 74
Fortunati N, Fissore F, Fazzari A, Becchis M, Comba A, Catalano MG, Berta L, Frairia R.
Sex steroid binding protein exerts a negative control on estradiol action in MCF-7
cells (human breast cancer) through cyclic adenosine 3′,5′-monophosphate and protein
kinase A.
Endocrinology.
1996;
137
686-692
- 75
Raineri M, Catalano M, Hammond GL, Avvakumov GV, Frairia R, Fortunati N.
O-Glycosylation of human sex hormone-binding globulin is essential for inhibition
of estradiol-induced MCF-7 breast cancer cell proliferation.
Mol Cell Endocrinol.
2002;
189
135-143
- 76
Cassoni P, Catalano M, Sapino A, Marrocco T, Fazzari A, Bussolati G, Fortunati N.
Oxytocin modulates estrogen receptor alpha expression and function in MCF7 human breast
cancer cells.
Int J Oncol.
2002;
21
375-378
- 77
Cassoni P, Sapino A, Forunati N, Munaron L, Chini B, Bussolati G.
Oxytocin inhibits the proliferation of MDA-MB231 human breast- cancer cells via cyclic
adenosine monophosphate and protein kinase A.
Int J Cancer.
1997;
72
340-344
- 78
Cassoni P, Fulcheri E, Carcangiu ML, Stella A, Deaglio S, Bussolati G.
Oxytocin receptors in human adenocarcinomas of the endometrium: presence and biological
significance.
J Pathol.
2001;
190
470-477
- 79
Cassoni P, Sapino A, Stella A, Bussolati G.
Antiproliferative effect of oxytocin through specific oxytocin receptors in human
neuroblastoma and astrocytoma cell lines.
Adv Exp Med Biol.
1998;
449
245-246
- 80
Herbert Z, Pollak EI, Molnar L, Caldwell JD, Jirikowski GF.
Co-transport of sex hormone binding globulin/SHBG with oxytocin in transport vesicle
of the hypothalamo-hypophyseal system.
Horm Metab Res.
2006;
38
291-293
- 81
Rodriguez A, Muller DC, Metter EJ, Maggio M, Harman SM, Blackman MR, Andres R.
Aging, androgens, and the metabolic syndrome in a longitudinal study of aging.
J Clin Endocrinol Metab.
2007;
92
3568-3572
- 82
Gapstur SM, Kopp P, Gann PH, Chiu BC, Colangelo LA, Liu K.
Changes in BMI modulate age-associated changes in sex hormone binding globulin and
total testosterone, but not bioavailable testosterone in young adult men: the CARDIA
Male Hormone Study.
Int J Obes (Lond).
2007;
31
685-691
- 83
Maggio M, Lauretani F, Ceda GP, Bandinelli S, Basaria S, Paolisso G, Ble A, Egan JM,
Metter EJ, Abbatecola AM, Zuliani G, Ruggiero C, Valenti G, Guralnik JM, Ferrucci L.
Association of hormonal dysregulation with metabolic syndrome in older women: data
from the InCHIANTI study.
Am J Physiol Endocrinol Metab.
2007;
292
E353-E358
- 84
Derby CA, Zilber S, Brambilla D, Morales KH, MacKinlay JB.
Body mass index, waist circumference and waist to hip ratio and change in sex steroid
hormones: the Massachusetts Male Ageing Study.
Clin Endocrinol (Oxf).
2007;
65
125-131
- 85
Garaulet M, Perez-Llamas F, Zamora S, Tebar FJ.
Interrelationship between serum lipid profile, serum hormones and other components
of the metabolic syndrome.
J Physiol Biochem.
2002;
58
151-160
- 86
Selva DM, Hogeveen KN, Innis SM, Hammond GL.
Monosaccharide-induced lipogenesis regulates the human hepatic sex hormone-binding
globulin gene.
J Clin Invest.
2007;
117
3979-3987
- 87
Haffner SM, Mykkanen L, Valdez RA, Katz MS.
Relationship of sex hormones to lipids and lipoproteins in nondiabetic men.
J Clin Endocrinol Metab.
1993;
77
1610-1615
- 88
Hamalainen E, Tikkanen H, Harkonen M, Naveri H, Adlercreutz H.
Serum lipoproteins, sex hormones and sex hormone binding globulin in middle-aged men
of different physical fitness and risk of coronary heart disease.
Atherosclerosis.
1987;
67
155-162
- 89
Tchernof A, Labrie F, Belanger A, Prud’homme D, Bouchard C, Tremblay A, Nadeau A,
Despres JP.
Relationships between endogenous steroid hormone, sex hormone-binding globulin and
lipoprotein levels in men: contribution of visceral obesity, insulin levels and other
metabolic variables.
Atherosclerosis.
1997;
133
235-244
- 90
Joseph DR, Lawrence W.
Mutagenesis of essential functional residues of rat androgen- binding protein/sex
hormone-binding globulin.
Mol Endocrinol.
1993;
7
488-496
- 91
Loukovaara M, Carson M, Adlercreutz H.
Regulation of production and secretion of sex hormone-binding globulin in HepG2 cell
cultures by hormones and growth factors.
J Clin Endocrinol Metab.
1995;
80
160-164
- 92
Wong AS, Lui WY, Hui IT, Lee WM.
Rabbit sex hormone-binding globulin: expression in the liver and testis during postnatal
development and structural characterization by truncated proteins.
Int J Androl.
2001;
24
165-174
- 93
Ciechanover A, Schwartzgll AL, Dautry-Varsat A, Lodish HF.
Kinetics of internalization and recycling of transferrin and the transferrin receptor
in a human hepatoma cell line effect of lysosomotropic agents.
J Biol Chem.
1983;
258
9681-9689
- 94
Caldwell JD, Suleman F, Jirikowski GF.
Internalization of sex hormone binding globulin into fibroblast 3T3 cells.
Horm Metab Res.
2007;
39
620-621
- 95
Tancevski I, Frank S, Massoner P, Stanzl U, Schgoer W, Wehinger A, Fievet C, Eller P,
Patsch JR, Ritsch A.
Increased plasma levels of LDL cholesterol in rabbits after adenoviral overexpression
of human scavenger receptor class B type I.
J Mol Med.
2005;
83
927-932
- 96
Hong SC, Zhao SP, Wu ZH.
Effect of probucol on HDL metabolism and class B type I scavenger receptor (SR-BI)
expression in the liver of hypercholesterolemic rabbits.
Int J Cardiol.
2007;
115
29-35
- 97
Peiris AN, Stagner JI, Plymate SR, Vogel RL, Heck M, Samols E.
Relationship of insulin secretory pulses to sex hormone binding globulin in normal
men.
J Clin Endocrinol Metab.
1993;
76
279-282
- 98
Asthana S.
Estrogen and cognition: a true relationship?.
J Am Geriatr Soc.
2004;
52
316-318
- 99
Buckwalter JG, Crooks VC, Robins SB, Pettiti DB.
Hormone use and cognitive performance in women of advanced age.
J Am Geriatr Soc.
2004;
52
182-186
- 100
Shilling V, Jenkins V, Fallowfield L, Howell A.
The effects of oestrogens and anti-oestrogens on cognition.
Breast.
2001;
10
484-491
- 101
Sherwin B.
Steroid hormones and cognitive functioning in aging men: a mini-review.
J Mol Neurosc.
2003;
20
385-393
- 102
Paoletti AM, Congia S, Lello S, Tedde D, Orru M, Pistis M, Pilloni M, Zedda P, Loddo A,
Melis GB.
Low androgenization index in elderly women and elderly men with Alzheimer's disease.
Neurology.
2004;
62
301-303
- 103
Moffat SD, Zonderman AB, Metter EJ, Kawas C, Blackman MR, Blackman MR, Harman SM,
Resnick SM.
Free testosterone and risk for Alzheimer disease in older men.
Neurology.
2004;
62
188-193
- 104
Hogervorst E, Bandelow S, Combrinck M, Smith AD.
Low free testosterone is an independent risk factor for Alzheimer's disease.
Exp Gerontol.
2004;
39
1633-1639
- 105
Bamberger ME, Harris ME, MacDonald DR, Husemann J, Landreth GE.
A cell surface receptor complex for fibrillar beta-amyloid mediates microglial activation.
J Neurosci.
2003;
23
2665-2674
- 106
Koenigsknecht J, Landreth G.
Microglial phagocytosis of fibrillar beta-amyloid through a beta1 integrin-dependent
mechanism.
J Neurosci.
2004;
24
9838-9846
- 107
Katzman R, Suzuki K.
A search for a chemical correlate of amyloid in senile plaques of Alzheimer's disease.
Trans Am Neurol Assoc.
1964;
89
17-20
- 108
Mandybur TI.
The incidence of cerebral amyloid angiopathy in Alzheimer's disease.
Neurology.
1975;
25
120-126
- 109
Miyakawa T, Shikai I, Shimoji A, Kuramoto R, Nagatoshi K.
Electron-microscopical study on senile plaques in Alzheimer's disease.
Folia Psychiatr Neurol Jpn.
1979;
33
197-203
- 110
Zhang Y, Da Silva JR, Reilly M, Billheimer JT, Rothblatt GH, Rader DJ.
Hepatic expression of scavenger receptor class B type I (SR-BI) is a positive regulator
of macrophage reverse cholesterol transport in vivo.
J Clin Invest.
2005;
115
2870-2874
- 111
Carro E, Spuch C, Trejo JL, Antequera D, Torres-Aleman I.
Choroid plexus megalin is involved in neuroprotection by serum insulin-like growth
factor I.
J Neurosc.
2005;
25
10884-10893
- 112
Kaptoge S, Dalzell N, Folkerd E, Doody D, Khaw KT, Beck TJ, Loverdige N, Mawer EB,
Berry JL, Shearer MJ, Dowsett M, Reeve J.
Sex hormone status may modulate rate of expansion of proximal femur diameter in older
women alongside other skeletal regulators.
J Clin Endocrinol Metab.
2007;
92
304-313
- 113
Lorentzon M, Swanson C, Andersson N, Mellstrom D, Ohlsson C.
Free testosterone is a positive, whereas free estradiol is a negative, predictor of
cortical bone size in young Swedish men: the GOOD study.
J Bone Miner Res.
2005;
20
1334-1341
- 114
Mellstrom D, Johnell O, Ljunggren O, Eriksson AL, Lorentzon M, Mallmin H, Holmberg A,
Redlund-Johnell I, Orwoll E, Ohlsson C.
Free testosterone is an independent predictor of BMD and prevalent fractures in elderly
men: MrOS Sweden.
J Bone Miner Res.
2006;
21
529-535
- 115
Ensrud KE, Lewis CE, Lambert LC, Taylor BC, Fink HA, Barrett-Connor E, Cauley JA,
Stefanick ML, Orwoll E.
Endogenous sex steroids, weight change and rates of hip bone loss in older men: the
MrOS study.
Osteoporos Int.
2006;
17
1329-1336
- 116
Strobach D, Lorenz RL.
The bisphosphonate ibandronate stimulates reverse cholesterol transport out of monocytoid
cells by enhanced ABCA1 transcription.
Biochem Biophys Res Commun.
2003;
307
23-30
- 117
Keenan MA.
Sexual dimorphism in stroke.
Orthop Clin North Am.
2006;
37
623-628
- 118
Moriyama IM, Woolsey TD.
Statistical studies of heart disease. IX. Race and sex differences in the trend of
mortality from the major cardiovascular-renal diseases.
Public Health Rep.
1951;
66
355-368
- 119
Smithwick RH, Bush RD, Kinsey D, Whitelaw GP.
Hypertension and associated cardiovascular disease; comparison of male and female
mortality rates and their influence on selection of therapy.
J Am Med Assoc.
1956;
160
1023-1026
- 120
Adlersberg D, Schaeffer LE, Steinberg AG, Wang CI.
Age, sex, serum lipids, and coronary atherosclerosis.
J Am Med Assoc.
1956;
162
619-622
- 121
Mjos OD, Thelle DS, Forde OH, Vik-Mo H.
Family study of high density lipoprotein cholesterol and the relation to age and sex.
The Tromso Heart Study.
Acta Med Scand.
1977;
201
323-329
- 122
Smith JB, Wade MB, Fineberg NS, Weinberger MH.
Sodium pump parameters of red blood cells in men, women and women taking oral contraceptives.
Clin Exp Hypertens A.
1986;
8
1189-1209
- 123
Hazzard WR, Applebaum-Bowden D.
Why women live longer than men: the biologic mechanism of the sex differential in
longevity.
Trans Am Clin Climatol Assoc.
1989;
101
168-188
- 124
Lapidus J, Lindstedt G, Lundberg P, Bengtsson C, Gredmark T.
Concentrations of sex-hormone binding globulin and corticosteroid binding globulin
in serum in relation to cardiovascular risk factors and to 12-year incidence of cardiovascular
disease and overall mortality in postmenopausal women.
Clin Chem.
1986;
32
146-152
- 125
Schock HW, Herbert Z, Sigusch H, Figulla HR, Jirikowski GF, Lotze U.
Expression of androgen-binding protein (ABP) in human cardiac myocytes.
Horm Metab Res.
2006;
38
225-229
- 126
Caldwell JD.
Central oxytocin and female sexual behavior.
Ann N Y Acad Sci.
1992;
652
166-179
- 127
Hadley M.
The adult biology of the Crane-fly Molophilus ater Meigen.
J Animal Ecol.
1969;
38
765-790
- 128
Rapuri PB, Gallagher JC, Haynatzki G.
Endogenous levels of serum estradiol and sex hormone binding globulin determine bone
mineral density, bone remodeling, the rate of bone loss, and response to treatment
with estrogen in elderly women.
J Clin Endocrinol Metab.
2004;
89
4954-4962
- 129
Leenen R, Kooy K van der, Seidell JC, Deurentberg P, Koppeschaar HP.
Visceral fat accumulation in relation to sex hormones in obese men and women undergoing
weight loss therapy.
J Clin Endocrinol Metab.
1994;
78
1515-1520
Correspondence
J. D. CaldwellPhD
Lake Erie College of Osteopathic Medicine
1858 West Grandview Avenue
Erie
PA 16509
USA
Phone: +1/814/860 51 53
Fax: +1/814/866 84 11
Email: jcaldwell@lecom.edu